Episode
Bladder Cancer
- Podcast
- Mayo Clinic Talks
- Published
- May 21, 2026
- Duration seconds
- 1716
- Processing state
not_requested- Canonical source
- https://mayoclinictalks.podbean.com/e/bladder-cancer/
Actions
POST https://stenobird.com/v1/public/podcasts/mayo-clinic-talks-750082/episodes/bladder-cancer/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/mayo-clinic-talks-750082/bladder-cancer.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Host: Darryl S. Chutka, M.D Guest: Mark D. Tyson, III, M.D., M.P.H. Bladder cancer is one of the most common malignancies worldwide, and primary care clinicians are often the first to evaluate patients with bladder cancer. The symptoms are usually subtle and may include either gross or microscopic hematuria. The decision in whether to investigate these presenting symptoms can often impact early diagnosis and the patient’s outcome. When should we investigate hematuria? What should an evaluation of hematuria consist of? What is the treatment for bladder cancer? How should patients with recurrent bladder cancer be managed? What role does the primary care clinician play in the long-term management of patients? I’ll be asking these questions and more of my guest, Dr. Mark Tyson, a urologist at the Mayo Clinic as we discuss “Bladder Cancer”. Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development